In summary, our study demonstrated the protective role of SCF/c-kit signaling on the retinal injury, and indicated exogenous SCF as a potent candidate for the treatment of retinal degeneration-related diseases. The gene discussed is KITLG; the disease is glycogen storage disease VI.